Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma;Perfil nutricional bioquímico de pacientes portadores de cirrose com carcinoma hepatocelular

Arquivos de Gastroenterologia

Volumn 51, Issue 1, 2014, Pages 10-15

  Port, Gabriela Zanatta ^a   Oliveira, Kalinca ^a   Soldera, Jonathan ^a   Tovo, Cristiane Valle ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Hepacivirus; Hepatocellular carcinoma; Liver cirrhosis; Malnutrition; Nutritional assessment

Indexed keywords

TRACE ELEMENT;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHILD TURCOTTE PUGH SCORE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; NUTRITIONAL ASSESSMENT; POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84898891078     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032014000100003     Document Type: Article

References (43)

1. Afzali A, Weiss NS, Boyko EJ, Ioannou GN. Association Between Serum Uric Acid Level and Chronic Liver Disease in the United States. Hepatology. 2010;52:578-89.
2. American Diabetes Association (ADA). Blood Glucose Level. Available from: http//:www.diabetes.org.
3. Bae HM, Lee JH, Yoon JH, Kim YJ, Heo DS, Lee HS. Protein induced by vitamin k absence or antagonist-ii production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective Evaluation. BMC Cancer. 2011; 435:1-11.
4. Boige V, Castera L, de Roux N, Ganne-Carrie N, Ducot B, Pelletier G, Beaugrand M, Buffet C. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis. Gut. 2003;52:1178-81.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an up to date. Hepatology. 2011;53:1020-2.
6. Buyukasik NS, Nadir I, Akin FE, Cakal B, Kav T, Ersoy O, Buyukafiik Y. Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description. Turk J Gastroenterol. 2011;22:606-11.
7. Cabré E, Gassull MA. Nutritional and metabolic issues in cirrhosis and liver transplantation. Curr Opin Clin Nutr Metab Care. 2000;3:345-54.
8. Fernandes AS, Bassani L, Nunes FF, Aydos MED, Alves AV, Marroni CA. Nutritional assessment in patients with cirrhosis. Arq Gastr. 2012;49:19-27.
9. Figueiredo FA, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M, DiCecco S, Francisco-Ziller N, Charlton M. Impact of nutritional status on outcome after liver transplantation. Transplantation. 2000;70:1347-52.
10. Fleming KA, McGee J. Alcohol induced liver disease. Journal of Clinical Pathology. 1984;37:721-33.
11. Franchini M, Targher G, Capra F, Montagnana M, Lippi G. The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int. 2008;2:335-40.
12. Gonçalves CS, Pereira FEL, Gayotto LCC. Hepatocellular carcinoma in Brazil: report of a national survey (Florianopolis, SC, 1995). Rev Inst Med Trop S Paulo. 1997;39:165-70.
13. Gunsar F, Riamondo ML, Jones S, Terreni N, Wong C, Patch D, Sabin C, Vurroughs AK. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther. 2006;24:563-72.
14. Habib A, Mihas AA, Abou-Assi SG, Williams LM, Gavis E, Pandak WM, Heuman DM. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol. 2005; 3:286-91.
15. Hambige M. Biomarkers of Trace Mineral Intake and Status. J Nutr. 2003;133:948-55.
16. Hehir DJ, Jenkins RL, Bistrian BR, Blackburn GL. Nutrition in patients undergoing orthotopic liver transplant. J Parenter Enteral Nutr. 1985;9:695-700.
17. Huang Y, Li LZ, Zhang CZY, Yi C, Liu LL, Zhou X, Xie GB, Cai MY, Li Y, Yun JP. Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis. Journal of Translational Medicine. 2012;10:106-21
18. Isoda K, Kagaya N, Akamatsu S, Hayashi S, Tamesada M, Watanabe A, Kobayashi M, Tagawa YI, Kondoh M, Kawase M, Yagi K. Hepatoprotective Effect Of Vitamin B12 On Dimethylnitrosamine-Induced Liver Injury. Biol Pharm Bull. 2008;31:309-11.
19. Jiang M, Liu F, Xiong WJ, Zhong L, Xu W, Xu F, Liu YB. Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis. World J Gastroenterology. 2010;16:1397-401.
20. Kane SP, Murray-lyon M, Paradinas J, Johnson J, Williams R, Orr H, Kohn J. Vitamin b12 binding protein as a tumour marker for hepatocellular carcinoma. Gut. 1978;19:1105-9.
21. Lieber CS. Nutrição nos distúrbios hepáticos. In: Shils ME, Olson JA, Shike M, Ross AK. Tratado de Nutrição Moderna na saúde e na doença. São Paulo: Manole; 2003. p.1257-69.
22. Lin CC, Yin MC. B Vitamins Deficiency and Decreased anti-oxidative state in Patients in Liver Cancer. Europe Journal of Nutrition. 2007;46:293-9.
23. Maio R, Dichi JB, Burini RC. Sensibility of anthropometric-laboratory markers of protein-energy malnutrition in cirrhotic patients. Arq Gastroenterol. 2004;41:93-9.
24. Matsuoka S, Matsumura H, Nakamura H, Oshiro S, Arakawa Y, Hayashi J, Sekine N, Nirei K, Yamagami H, Ogawa M, Nakajima N, Amaki S, Tanaka N, Moriyama M. Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis. J Clin Biochem Nutr. 2003;45:292-303.
25. Mattos AA, Coral GP, Menti E, Valiatti F, Kramer C. Infecção bacteriana no paciente cirrótico. Arq Gastr. 2003;40:11-5.
26. Menezes MO, Tovo CV, Mattos AA. Associação entre a hepatite crônica pelo vírus da hepatite C (VHC) e diabete melito em pacientes monoinfectados pelo VHC e co-infectados com o vírus da imunodeficiência humana. Revista da AMRIGS. 2008;52:17-23.
27. Nazari MA, Malayeri SH, Pourhoseingholi MA, Mohebi SR, Zali MR. Evaluation of Zinc Plasma Level in Iranian Cirrhotic Patients due to Hepatitis B and Hepatitis C. Hepatitis Monthly. 2010;10:62-4.
28. Pascale RM, De Miglio MR, Muroni MR, Simile MM, Daino L, Seddaiu MA, Pusceddu S, Gaspa L, Calvisi D, Manenti G, Feo F. Transferrin and Transferrin Receptor Gene Expression and Iron Uptake in Hepatocellular Carcinoma in the Rat. Hepatology. 1998;27:452-61.
29. Piquet MA, Ollivier I, Gloro R, Castel H, Tiengou LE, Dao T. Nutritional indices in cirrhotic patients. Nutrition. 2006;22:216-7.
30. Price L, Kowdley K. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterology. 2009;23:822-8.
31. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MV, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
32. Ritter L, Gazzola J. Avaliação nutricional no paciente cirrótico: uma abordagem objetiva, subjetiva ou multicompartimental? Arq Gastr. 2006;43:66-70.
33. Rosa H, Silvério AO, Perini RF, Arruda CB. Bacterial infection in cirrhotic patients and its relationship with alcohol. Gastroenterology. 2000;95:1290-3.
34. Sam J, Nguyen GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver International. 2009;29:1396-402.
35. Selcuk H, Uruc I, Temel MA, Ocal S, Huddam B, Korkmaz M, Unal H, Kanbay M, Savas N, Gur G, Yilmaz U, Haberal M. Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Dig Dis Sci. 2007;52:3217-23.
36. Siriboonkoom W, Gramlich L. Nutrition and chronic liver disease. Can J Gastroenterol. 1998;12:201-7.
37. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. New Jersey: John Wiley & Sons; 2002.
38. Tan MGK, Kumarasinghe MP, Wang SM, Lucien LPJ, Aw SE, Hui KM. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med. 2009;234:693-702.
39. Tandon P, Gramlich L, Lipman TO, Bonis PAL. Nutritional assessment in chronic liver disease. Up ToDate, 2010.
40. Tisdale MJ. Cancer anorexia and cachexia. Nutrition 2001;17:438-42.
41. Vulcano, DSB. Avaliação dos indicadores nutricionais em hepatopatas crônicos e a relação com a etiologia e gravidade da doença. [Dissertação de mestrado]. Botucatu: Faculdade de Medicina de Botucatu, Universidade Estadual Paulista; 2010.
42. World Health Organization (WHO). Physical status: the use and interpretation of anthropometry. Geneva. WHO, 1995 (WHO-technical report series 854).
43. Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C. Association between metabolic abnormalities and HBV related hepatocellular carcinoma in Chinese: A cross-sectional study. Nutrition Journal. 2011;10:1-8.